Delivery Order SPE2DR25D2007-SPE2DR26FM12A
- Not listed
- The Defense Logistics Agency awarded a $13,296.58 firm fixed price delivery order to AmerisourceBergen Drug Corp for 84 tablets of Mavyret 100-40 mg on July 17, 2025, with an ultimate completion date of July 18, 2025. The contract, which is not set-aside, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99...
- This is a $8,582.36 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation. The contract is for the supply of MAVYRET 100-40 MG TABLET 84S, a pharmaceutical product, with a period of performance through April 8, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corporation is a major pharmaceutical distributor and healthcare solutions provider that plays a critical...
- The Defense Logistics Agency Troop Support awarded a $47,186.60 firm fixed price delivery order contract to Amerisourcebergen Drug Corporation for 4555753915 MAVYRET 100-40 MG TABLET 84S. MAVYRET is a direct-acting antiviral medication used to treat chronic hepatitis C virus infections. The place of performance is Conshohocken, Pennsylvania. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation. No set aside designation was used for this award to support the...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a firm fixed-price delivery order valued at $17,524.44 to AmerisourceBergen Drug Corp on July 27, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $34,535.20 to AmerisourceBergen Drug Corp on August 27, 2025, with an ultimate completion date of August 28, 2025. This firm fixed-price, non-set-aside contract is a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $7,957.71 to AmerisourceBergen Drug Corp on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order is a non-set-aside contract and represents a child action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The work will be performed at the contractor's corporate office location in Conshohocken,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $15,033.30 delivery order (Contract 4569946721) to AmerisourceBergen Drug Corp on November 7, 2025, with completion scheduled for November 10, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award based on the vendor's demonstrated capabilities. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform all work at its...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $16,589.43 to AmerisourceBergen Drug Corp on July 26, 2025, with ultimate completion by July 28, 2025. This firm fixed-price, non-set-aside delivery order represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $17,040 to AmerisourceBergen Drug Corp on September 16, 2025, with an ultimate completion date of September 17, 2025. This firm fixed price delivery order, issued under contract number 4569466091, represents a non-set-aside competitive award to supply pharmaceutical products and medical supplies to support federal healthcare operations. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $57,139.66 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 6, 2025, with an ultimate completion date of the same day. This non-set-aside contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (valued at $999,999,999.00 and running through December 2026) with DLA Troop Support Medical. The delivery order is designated for the Pharmaceutical Prime Vendor Division and...
- SPE2DR25D2007Indefinite Delivery Contract
- SPE2DR25D2007-SPE2DR26FM12ADelivery Order
The Defense Logistics Agency awarded a $17,709.89 delivery order to AmerisourceBergen Drug Corp for the supply of Mavyret 100-40 mg tablets (84-count units) on November 12, 2025, with an ultimate completion date of November 13, 2025. This is a firm fixed-price, non-set-aside contract performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion comprehensive pharmaceutical support vehicle running through December 2026 that enables the contractor to supply medications and medical supplies to military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has demonstrated consistent capability in meeting federal procurement requirements through open competition across a wide spectrum of pharmaceutical products. The company's extensive portfolio with the Defense Logistics Agency encompasses brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order for Mavyret, an antiviral hepatitis C medication, reflects the contractor's ongoing role as a critical vendor supporting military and veteran healthcare needs through the DLA's Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.7k | 11/12/25 |